日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects

利用非基因工程改造的多抗原靶向T细胞进行淋巴瘤T细胞疗法安全有效,且能产生持久的临床疗效。

Vasileiou, Spyridoula; Lulla, Premal D; Tzannou, Ifigeneia; Watanabe, Ayumi; Kuvalekar, Manik; Callejas, Wendy L; Bilgi, Mrinalini; Wang, Tao; Wu, Mengfen J; Kamble, Rammurti; Ramos, Carlos A; Rouce, Rayne H; Zeng, Zihua; Gee, Adrian P; Grilley, Bambi J; Vera, Juan F; Bollard, Catherine M; Brenner, Malcolm K; Heslop, Helen E; Rooney, Cliona M; Leen, Ann M; Carrum, George

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

异基因移植后,向急性髓系白血病/骨髓增生异常综合征患者输注白血病特异性供体T细胞的临床效果

Lulla, Premal D; Naik, Swati; Vasileiou, Spyridoula; Tzannou, Ifigeneia; Watanabe, Ayumi; Kuvalekar, Manik; Lulla, Suhasini; Carrum, George; Ramos, Carlos A; Kamble, Rammurti; Hill, LaQuisa; Randhawa, Jasleen; Gottschalk, Stephen; Krance, Robert; Wang, Tao; Wu, Mengfen; Robertson, Catherine; Gee, Adrian P; Chung, Betty; Grilley, Bambi; Brenner, Malcolm K; Heslop, Helen E; Vera, Juan F; Leen, Ann M

A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial

一项针对缺血性心力衰竭患者的自体间充质干细胞和c-kit阳性心肌细胞单独或联合治疗的II期研究:CCTRN CONCERT-HF试验

Bolli, Roberto; Mitrani, Raul D; Hare, Joshua M; Pepine, Carl J; Perin, Emerson C; Willerson, James T; Traverse, Jay H; Henry, Timothy D; Yang, Phillip C; Murphy, Michael P; March, Keith L; Schulman, Ivonne H; Ikram, Sohail; Lee, David P; O'Brien, Connor; Lima, Joao A; Ostovaneh, Mohammad R; Ambale-Venkatesh, Bharath; Lewis, Gregory; Khan, Aisha; Bacallao, Ketty; Valasaki, Krystalenia; Longsomboon, Bangon; Gee, Adrian P; Richman, Sara; Taylor, Doris A; Lai, Dejian; Sayre, Shelly L; Bettencourt, Judy; Vojvodic, Rachel W; Cohen, Michelle L; Simpson, Lara; Aguilar, David; Loghin, Catalin; Moyé, Lem; Ebert, Ray F; Davis, Barry R; Simari, Robert D

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

抗CD30 CAR-T细胞疗法治疗复发难治性霍奇金淋巴瘤

Ramos, Carlos A; Grover, Natalie S; Beaven, Anne W; Lulla, Premal D; Wu, Meng-Fen; Ivanova, Anastasia; Wang, Tao; Shea, Thomas C; Rooney, Cliona M; Dittus, Christopher; Park, Steven I; Gee, Adrian P; Eldridge, Paul W; McKay, Kathryn L; Mehta, Birju; Cheng, Catherine J; Buchanan, Faith B; Grilley, Bambi J; Morrison, Kaitlin; Brenner, Malcolm K; Serody, Jonathan S; Dotti, Gianpietro; Heslop, Helen E; Savoldo, Barbara

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial

蒽环类药物诱发心肌病心力衰竭患者的异体间充质细胞疗法:CCTRN SENECA试验

Bolli, Roberto; Perin, Emerson C; Willerson, James T; Yang, Phillip C; Traverse, Jay H; Henry, Timothy D; Pepine, Carl J; Mitrani, Raul D; Hare, Joshua M; Murphy, Michael P; March, Keith L; Ikram, Sohail; Lee, David P; O'Brien, Connor; Durand, Jean-Bernard; Miller, Kathy; Lima, Joao A; Ostovaneh, Mohammad R; Ambale-Venkatesh, Bharath; Gee, Adrian P; Richman, Sara; Taylor, Doris A; Sayre, Shelly L; Bettencourt, Judy; Vojvodic, Rachel W; Cohen, Michelle L; Simpson, Lara M; Lai, Dejian; Aguilar, David; Loghin, Catalin; Moyé, Lem; Ebert, Ray F; Davis, Barry R; Simari, Robert D

Two Decades of Global Progress in Authorized Advanced Therapy Medicinal Products: An Emerging Revolution in Therapeutic Strategies

二十年来全球获批先进疗法药品取得的进展:治疗策略的新兴革命

Ramezankhani, Roya; Torabi, Shukoofeh; Minaei, Neda; Madani, Hoda; Rezaeiani, Siamak; Hassani, Seyedeh Nafiseh; Gee, Adrian P; Dominici, Massimo; Silva, Daniela Nascimento; Baharvand, Hossein; Hajizadeh-Saffar, Ensiyeh

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients.

脐带血来源病毒特异性 T 细胞在脐带血移植受者中的安全性和可行性

Abraham Allistair A, John Tami D, Keller Michael D, Cruz C Russell N, Salem Baheyeldin, Roesch Lauren, Liu Hao, Hoq Fahmida, Grilley Bambi J, Gee Adrian P, Dave Hema, Jacobsohn David A, Krance Robert A, Shpall Elizabeth J, Martinez Caridad A, Hanley Patrick J, Bollard Catherine M

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma

经基因工程改造可克服肿瘤免疫逃逸的肿瘤特异性T细胞,在复发性霍奇金淋巴瘤患者中诱导临床反应

Bollard, Catherine M; Tripic, Tamara; Cruz, Conrad Russell; Dotti, Gianpietro; Gottschalk, Stephen; Torrano, Vicky; Dakhova, Olga; Carrum, George; Ramos, Carlos A; Liu, Hao; Wu, Meng-Fen; Marcogliese, Andrea N; Barese, Cecilia; Zu, Youli; Lee, Daniel Y; O'Connor, Owen; Gee, Adrian P; Brenner, Malcolm K; Heslop, Helen E; Rooney, Cliona M

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

EBV/LMP特异性T细胞在同种异体骨髓移植后维持T细胞和B细胞EBV淋巴瘤的缓解

McLaughlin, Lauren P; Rouce, Rayne; Gottschalk, Stephen; Torrano, Vicky; Carrum, George; Wu, Meng-Fen; Hoq, Fahmida; Grilley, Bambi; Marcogliese, Andrea M; Hanley, Patrick J; Gee, Adrian P; Brenner, Malcolm K; Rooney, Cliona M; Heslop, Helen E; Bollard, Catherine M

TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis

TIME试验:ST段抬高型心肌梗死后干细胞输注时机对整体和局部左心室功能恢复的影响:最终2年分析

Traverse, Jay H; Henry, Timothy D; Pepine, Carl J; Willerson, James T; Chugh, Atul; Yang, Phillip C; Zhao, David X M; Ellis, Stephen G; Forder, John R; Perin, Emerson C; Penn, Marc S; Hatzopoulos, Antonis K; Chambers, Jeffrey C; Baran, Kenneth W; Raveendran, Ganesh; Gee, Adrian P; Taylor, Doris A; Moyé, Lem; Ebert, Ray F; Simari, Robert D